H.C. Wainwright analyst Joseph Pantginis adjusted the firm’s price target on BiomX (PHGE) to $26 from $15 and keeps a Buy rating on the shares. The adjusted target follows the company’s reverse stock split.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHGE: